IP Library › Granted Patent US 9,884,817
Granted Patent B2
US 9,884,817 · App. 15/317,532 · Granted Feb 6, 2018

Auristatin derivatives and conjugates thereof

Inventors: Bernhard Hubert Geierstanger (Solana Beach, CA); Jan Grunewald (San Diego, CA); Weijia Ou (San Diego, CA); Shifeng Pan (San Diego, CA); Tetsuo Uno (San Diego, CA); Yongqin Wan (San Diego, CA); Xing Wang (San Diego, CA)
Assignee: Novartis AG
C07D207/09A61K47/48384A61K47/48561C07D401/12C07D403/12C07D403/14C07D413/12C07K16/32
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,884,817
App. No.
15/317,532
Granted
Feb 6, 2018
Kind
B2
Abstract

Disclosed herein are novel compounds of formula (I) as described herein: and the use of such peptides in making immunoconjugates (i.e Antibody Drug Conjugates) Also described herein are immunoconjugates (i.e Antibody Drug Conjugates) comprising such novel compound linked to an antigen binding moiety, such as an antibody; where such immunoconjugates are useful for treating cell proliferative disorders. The invention further provides pharmaceutical compositions comprising these immunoconjugates, compositions comprising the immunoconjugates with a therapeutic co-agent, and methods to use these immunoconjugates and compositions for treating cell proliferation disorders.

Claims (146)

1. An immunoconjugate of Formula (II):

wherein:

Ab represents an antigen binding moiety;

R 101 is

 —NHC(═O)NR 6 *—, —NHR 121 *—,

 or —NHC(═O)R 123 *—, where the * denotes the point of attachment to L;

R 2 is —C 1 -C 6 alkyl;

R 3 is

R 5 is N(R 6 ) 2 ;

each R 6 is independently selected from H and —C 1 -C 6 alkyl;

R 9 is —OH, C 1 -C 6 alkoxy, —N(R 12 ) 2 , —R 16 , —NR 12 (CH 2 ) m N(R 12 ) 2 , —NR 12 (CH 2 ) m R 16 , —NHS(O) 2 R 18 or

each R 12 is independently selected from H and C 1 -C 6 alkyl;

R 15 is tetrazolyl,

R 16 is an N-linked 4-8 membered heterocycloalkyl containing 1-2 heteroatoms independently selected from N, O, S, S(═O) and S(═O) 2 , which is unsubstituted or substituted with -LR 11

each R 18 is independently selected from a C 1 -C 6 alkyl, a C 1 -C 6 alkyl which is substituted with azido and a C 1 -C 6 alkyl which is substituted with 1 to 5 hydroxyl;

R 110 is a bond or

R 121 is a C-linked 5-6 membered heteroarylene having 1-2 N heteroatoms which is substituted with 0-2 substituents independently selected from C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, halogen, —CN, NO 2 , —C(═O)OR 6 , —C(═O)N(R 6 ) 2 and C 1 -C 6 alkoxy;

R 122 is a C-linked 5-6 membered heterocycloalkylene having 1-2 heteroatoms independently selected from N, O and S which is substituted with 0-2 substituents independently selected from C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, halogen and C 1 -C 6 alkoxy;

R 123 is an N-linked 5-6 membered heterocycloalkylene having 1-2 heteroatoms independently selected from N and O which is substituted with 0-2 substituents independently selected from C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, halogen and C 1 -C 6 alkoxy;

L is selected from -L 1 L 2 L 3 L 4 L 5 L 6 -, -L 6 L 5 L 4 L 3 L 2 L 1 -, -L 1 L 2 L 3 L 4 L 5 -, -L 5 L 4 L 3 L 2 L 1 -, -L 1 L 2 L 3 L 4 -, -L 4 L 3 L 2 L 1 -, -L 1 L 2 L 3 -, -L 3 L 2 L 1 -, -L 1 L 2 -, -L 2 L 1 - and -L 1 ,

wherein

L 1 is selected from:

—(CH 2 ) m —, —C(═O)(CH 2 ) m —, —NR 12 C(═O)(CH 2 ) m —, —C(═O)X 1 X 2 C(═O)(CH 2 ) m —, —C(═O)X 1 X 2 C(═O)(CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —C(═O)X 1 X 2 C(═O)(CH 2 ) m X 3 (CH 2 ) m —, —C(═O)X 1 X 2 C(═O)((CH 2 ) m O) n (CH 2 ) m —, —C(═O)X 1 X 2 C(═O)((CH 2 ) m O) n (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —C(═O)X 1 X 2 C(═O)((CH 2 ) m O) n (CH 2 ) m NR 12 C(═O)(CH 2 ) m X 3 (CH 2 ) m —, —C(═O)X 1 X 2 C(═O)((CH 2 ) m O)(CH 2 ) m X 3 (CH 2 ) m —, —C(═O)X 1 X 2 C(═O)(CH 2 ) m NR 12 C(═O)((CH 2 ) m O) n (CH 2 ) m —, —C(═O)X 1 X 2 C(═O)(CH 2 ) m NR 12 C(═O)((CH 2 ) m O) n (CH 2 ) m X 3 (CH 2 ) m —, —C(═O)X 1 X 2 (CH 2 ) m X 3 (CH 2 ) m —, —C(═O)X 1 X 2 ((CH 2 ) m O) n (CH 2 ) m —, —C(═O)X 1 X 2 ((CH 2 ) m O) n (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —C(═O)X 1 X 2 ((CH 2 ) m O) n (CH 2 ) m NR 12 C(═O)(CH 2 ) m X 3 (CH 2 ) m —, —C(═O)X 1 X 2 ((CH 2 ) m O) n (CH 2 ) m X 3 (CH 2 ) m —, —C(═O)X 1 X 2 (CH 2 ) m NR 12 ((CH 2 ) m O) n (CH 2 ) m —, —C(═O)X 1 X 2 C(═O)(CH 2 ) m NR 12 ((CH 2 ) m O) n (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —C(═O)((CH 2 ) m O) n (CH 2 ) m —, —(CH 2 ) m S(═O) 2 ((CH 2 ) m O) n (CH 2 ) m —, —C(═O)(CH 2 ) m NR 12 (CH 2 ) m —, —C(═O)NR 12 (CH 2 ) m —, —C(═O)NR 12 (CH 2 ) m X 3 (CH 2 ) m —, —C(═O)NR 12 (CH 2 ) m NR 12 C(═O)X 1 X 2 C(═O)(CH 2 ) m —, —C(═O)X 1 C(═O)NR 12 (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —C(═O)X 1 C(═O)NR 12 (CH 2 ) m X 3 (CH 2 ) m —, —C(═O)NR 12 (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —C(═O)NR 12 (CH 2 ) m NR 12 C(═O)(CH 2 ) m X 3 (CH 2 ) m —,

 (CH 2 ) m C(═O)NR 12 (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)—, —C(═O)(CH 2 ) m NR 12 (CH 2 ) m C(═O)X 2 X 1 C(═O)—, —(CH 2 ) m X 3 (CH 2 ) m C(═O)X 2 X 1 C(═O)—, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m X 3 —, —X 3 (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m C(O)NR 12 (CH 2 ) m —, —(CH 2 ) m NR 12 C(═O)(CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m O)(CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m (O(CH 2 ) m ) n —, —((C(R 12 ) 2 ) m OC(═O)NR 12 (CH 2 ) m O(CH 2 ) m —, —(CH 2 ) m (O(CH 2 ) m ) n NR 12 C(O)O(C(R 12 ) 2 ) m —, —(CH 2 ) m (O(CH 2 ) m ) n C(O)—, —(CH 2 ) m (O(CH 2 ) m ) n S(O) 2 (CH 2 ) m —, —(CH 2 ) m NR 12 (CH 2 ) m C(═O)—, —(CH 2 ) m O(CH 2 ) m NR 12 C(O)O((C(R 12 ) 2 ) m —, —(CH 2 ) m NR 12 C(═O)—, —(CH 2 ) m C(═O)X 2 X 1 C(═O)NR 12 (CH 2 ) m NR 12 (═O)—, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m NR 12 C(═O)X 1 —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m NR 12 C(═O),

 —((CH 2 ) m O) n (CH 2 ) m —, —(CH 2 ) m (O(CH 2 ) m ) n —, —(CH 2 ) m (O(CH 2 ) m ) n X 3 (CH 2 ) m —, —(CH 2 ) m X 3 ((CH 2 ) m O) n (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m C(═O)—, —C(═O)(CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m O) n (CH 2 ) m X 3 —, —X 3 (CH 2 ) m (O(CH 2 ) m ) n NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m O) n (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m (O(CH 2 ) m ) n NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m (O(CH 2 ) m ) n C(═O)—, —C(═O)((CH 2 ) m O) n (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m C(═O)—, —C(═O)(CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m (O(CH 2 ) m ) n C(═O)—, —C(═O)((CH 2 ) m O) n (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m C(═O)NR 12 (CH 2 ) m —, —(CH 2 ) m NR 12 C(═O)(CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —C(═O)NR 12 (CH 2 ) m NR 12 C(═O)—, —(CH 2 ) m S(CH 2 ) m —, —NR 12 C(═O)(CH 2 ) m —, —NR 12 C(═O)(CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m C(O)NR 12 —, —(CH 2 ) m C(═O)NR 12 —, —(CH 2 ) m NR 12 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 —, —X 3 (CH 2 ) m —, —((CH 2 ) m O) n (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m (O(CH 2 ) m ) n —, —NR 12 (CH 2 ) m —, —NR 12 C(R 12 )2(CH 2 ) m —, —(CH 2 ) m C(R 12 ) 2 NR 12 —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m NR 12 —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m NR 12 C(═O)NR 12 —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m NR 12 C(═O)—, —(CH 2 ) m C(═O)X 2 X 1 C(═O)—, —NR 12 (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —NR 12 C(R 12 )2(CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m C(R 12 ) 2 NR 12 , —NR 12 (CH 2 ) m X 3 (CH 2 ) m —, —NR 12 C(R 12 ) 2 (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m C(R 12 ) 2 NR 12 —, —NR 12 C(R 12 ) 2 (CH 2 ) m OC(O)NR 12 (CH 2 ) m —, —(CH 2 ) m NR 12 C(═O)O(CH 2 ) m C(R 12 ) 2 NR 12 —, —NR 12 C(R 12 ) 2 (CH 2 ) m OC(═O)NR 12 (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m NR 12 C(O)O(CH 2 ) m C(R 12 ) 2 NR 12 , —NR 12 C(R 12 ) 2 (CH 2 ) m OC(═O)NR 12 ((CH 2 ) m O) n (CH 2 ) m —, —(CH 2 ) m (O(CH 2 ) m ) n NR 12 C(═O)O(CH 2 ) m C(R 12 ) 2 NR 12 —, —NR 12 C(R 12 ) 2 (CH 2 ) m OC(═O)NR 12 ((CH 2 ) m O) n (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m (O(CH 2 ) m ) n NR 12 C(O)O(CH 2 ) m C(R 12 ) 2 NR 12 —, —(CH 2 ) m X 3 (CH 2 ) m NR 12 —, —NR 12 ((CH 2 ) m O) n (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m (O(CH 2 ) m ) n NR 12 —, —(CH 2 ) m NR 12 —, —NR 12 ((CH 2 ) m O) n (CH 2 ) m —, —NR 12 ((CH 2 ) m O) n (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m (O(CH 2 ) m ) n NR 12 —, —(CH 2 ) m (O(CH 2 ) m ) n NR 12 —, —(C(R 12 ) 2 ) m —, —(CH 2 CH 2 O) n —, —(OCH 2 CH 2 ) n —, —(CH 2 ) m O(CH 2 ) m —, —S(═O) 2 (CH 2 ) m —, —(CH 2 ) m S(═O) 2 —, —S(═O) 2 (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m S(═O) 2 —, —S(═O) 2 (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m S(═O) 2 —, —(CH 2 ) m X 2 X 1 C(═O)—, —C(═O)X 1 X 2 (CH 2 ) m —, —(CH 2 ) m (O(CH 2 ) m ) n C(═O)X 2 X 1 C(═O)—, —C(═O)X 1 X 2 C(═O)((CH 2 ) m O) n (CH 2 ) m —, —(CH 2 ) m (O(CH 2 ) m ) n X 2 X 1 C(═O)—, —(CH 2 ) m X 3 (CH 2 ) m X 2 X 1 C(═O)—, —C(═O)X 1 X 2 (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m (O(CH 2 ) m ) n X 2 X 1 C(═O)—, —(CH 2 ) m X 3 (CH 2 ) m C(O)NR 12 (CH 2 ) m NR 12 C(═O), —(CH 2 ) m X 3 (CH 2 ) m C(O)NR 12 (CH 2 ) m C(═O)—, —C(═O)(CH 2 ) m NR 12 C(═O(CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m C(O)NR 12 (CH 2 ) m (O(CH 2 ) m ) n C(═O)—, —C(═O)((CH 2 ) m O) n (CH 2 ) m NR 12 C(═O)(CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m NR 12 C(═O)X 1 X 2 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)X 2 X 1 C(═O)NR 12 (CH 2 ) m —, —X 4 X 1 X 2 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)X 2 X 1 X 4 -, —X 1 C(═O)(CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(O)NR 12 (CH 2 ) m C(═O)X 1 —, —C(═O)CHR aa NR 12 —, —NR 12 CHR aa C(═O)—, —C(═O)NR 12 —, —C(═O)O—, —S—, —SCH 2 (C═O)NR 12 —, —NR 12 C(═O)CH 2 S—, —S(═O) 2 CH 2 CH 2 S—, —SCH 2 CH 2 S(═O) 2 —, —(CH 2 ) 2 S(═O) 2 CH 2 CH 2 S—, —SCH 2 CH 2 S(═O) 2 CH 2 CH 2 —, —NR 12 C(═S)—, —(CH 2 ) m X 3 (O(CH 2 ) m ) n C(═O)—, —C(═O)((CH 2 ) m O) n X 3 (CH 2 ) m —, —(CH 2 ) m NR 12 C(═O)((CH 2 ) m O) n (CH 2 ) m —, —(CH 2 ) m (O(CH 2 ) m ) n C(═O)NR 12 (CH 2 ) m —, —(CH 2 ) m NR 12 C(O)NR 12 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m NR 12 C(═O)—, —C(═O)NR 12 (CH 2 ) m X 3 (CH 2 ) m —, —NR 12 S(═O) 2 (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m S(O) 2 NR 12

R 24 is H or Me;

each R 25 is independently selected from H or C 1-4 alkyl;

R 26 is

R aa is H or a side chain of an amino acid selected from alanine, tryptophan, tyrosine, phenylalanine, leucine, isoleucine, valine, asparagine, glutamic acid, glutamine, aspatic acid, histidine, arginine, lysine, cysteine, methionine, serine, threonine, citrulline, ornithine, phenylglycine and t-butylglycine;

R 30 is H, —CH 3 or phenyl;

R 32 is independently selected from H, C 1-4 alkyl, phenyl, pyrimidine and pyridine;

R 33 is independently selected from

R 34 is independently selected from H, C 1-4 alkyl, and C 1-6 haloalkyl;

X 1 is self immolative spacer selected from

X 2 is dipeptide selected from

X 3 is

X 4 is

y is an integer from 1 to 16;

L 2 , L 3 , L 4 , L 5 , and L 6 are each independently selected from a bond and L 1 ;

each m is independently selected from 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10,

and

each n is independently selected from 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 and 18.

2. The immunoconjugate of claim 1 , wherein:

R 101 is

and R 110 is a bond.

3. The immunoconjugate of claim 1 , wherein:

R 110

and R 110 is

4. The immunoconjugate of claim 1 , wherein

R 9 is —OH, C 1 -C 6 alkoxy, —N(R 14 ) 2 , —R 16 , —NR 12 (CH 2 ) m N(R 12 ) 2 , —NHS(O) 2 R 18 , or —NR 12 (CH 2 ) m R 16 ;

and

R 15 is tetrazolyl,

5. The immunoconjugate of claim 1 , wherein R 12 is H, —CH 3 or —CH 2 CH 3 .

6. The immunoconjugate of claim 1 , wherein R 2 is methyl, ethyl, isopropyl or sec-butyl.

7. The immunoconjugate of claim 1 , wherein:

L 1 is —(CH 2 ) m NHC(═O)(CH 2 ) m X 3 (CH 2 ) m *—, —(CH 2 ) m C(═O)*—, —(CH 2 ) m —, —(CH 2 ) m C(═O)X 2 X 1 C(═O)*—, —(CH 2 ) m X 2 X 1 C(═O)*—, —(CH 2 ) m (O(CH 2 ) m ) n C(═O)*—, —(CH 2 ) m (O(CH 2 ) m ) n C(═O)X 2 X 1 C(═O)*—, —(CH 2 ) m (O(CH 2 ) m ) n X 2 X 1 C(═O)*—, —(CH 2 ) m (O(CH 2 ) m ) n S(═O) 2 (CH 2 ) m *—, —(CH 2 ) m NR 12 (CH 2 ) m C(═O)*—, —X 3 (CH 2 ) m *—, —(CH 2 ) m C(═O)NH*—, —(CH 2 ) m NH(CH 2 ) m C(═O)*—, —((CH2) m O) n (CH2) m *—, —(CH 2 ) m X 3 (CH 2 ) m C(═O)*—, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m NR 12 *—, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m NR 12 C(═O)NH*—, —(CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m C(═O)X 2 X 1 C(═O)*—, —(CH 2 ) m X 3 (CH 2 ) m X 2 X 1 C(═O)*—, —(CH 2 ) m X 3 (CH 2 ) m (O(CH 2 ) m ) n X 2 X 1 C(═O)*—, —(CH 2 ) m NHC(═O)*—, —(CH 2 ) m X 3 (CH 2 ) m (O(CH 2 ) m ) n C(═O)*—, —(CH 2 ) m X 3 ((CH 2 ) m O) n (CH 2 ) m *—, —(CH 2 ) m C(═O)NH(CH 2 ) m *—, —(CH 2 ) m X 3 (CH 2 ) m C(═O)NH(CH 2 ) m *—, —(CH 2 ) m C(═O)NH(CH 2 ) m NHC(═O)*—, —(CH 2 ) m X 3 (CH 2 ) m NHC(═O)*—, —(CH 2 ) m C(═O)NH(CH 2 ) m C(═O)*—, —(CH 2 ) m X 3 (CH 2 ) m C(═O)NH(CH 2 ) m NHC(═O)*—, —(CH 2 ) m X 3 (CH 2 ) m C(═O)NH(CH 2 ) m C(═O)*—, —(CH 2 ) m C(═O)NH(CH 2 ) m (O(CH 2 ) m ) n C(═O)*—, —(CH 2 ) m X 3 (CH 2 ) m C(═O)NH(CH 2 ) m (O(CH 2 ) m ) n C(═O)*—, —(CH 2 ) m C(═O)NH(CH 2 ) m NHC(═O)(CH 2 ) m *—, —(CH 2 ) m X 3 (CH 2 ) m NHC(═O)(CH 2 ) m *—, —X 3 (CH 2 ) m NHC(═O)(CH 2 ) m *—, —(CH 2 ) m (O(CH 2 ) m ) n *—, —(CH 2 ) m C(═O)NH(CH 2 ) m (O(CH 2 ) m ) n *—, —X 3 (CH 2 ) m (O(CH 2 ) m ) n NHC(═O)(CH 2 ) m *—, —(CH 2 ) m X 3 (CH 2 ) m (O(CH 2 ) m ) n NHC(═O)(CH 2 ) m *—, —(CH 2 ) m C(═O)NH(CH 2 ) m C(═O)NH(CH 2 ) m *—, —(CH 2 ) m X 3 (CH 2 ) m C(═O)NH(CH 2 ) m *—, —(CH 2 ) m O(CH 2 ) m NHC(═O)O((C(R 2 ) 2 ) m *—, —(CH 2 ) m S(═O) 2 *- and —(CH 2 ) m X 3 (CH 2 ) m S(═O) 2 *—, wherein the * of L 1 indicates the point of attachment to R 101 ;

L 2 is

—S—, —SCH 2 (C═O)NH—, —NHC(═O)CH 2 S—, —NH(═O)CH 2 CH 2 S—, —SCH 2 CH 2 C(═O)NH—, —S(═O) 2 CH 2 CH 2 S—, —SCH 2 CH 2 S(═O) 2 —, —(CH 2 ) 2 S(═O) 2 CH 2 CH 2 S— or —SCH 2 CH 2 S(═O) 2 CH 2 CH 2 —, wherein the * of L 2 indicates the point of attachment to L 1 ,

and L 3 , L 4 , L 5 and L 6 are a bond.

8. The immunoconjugate of claim 1 , wherein:

L 1 is selected from —(CH 2 ) m C(═O)*—, —(CH 2 ) m X 3 (CH 2 ) m C(═O)*—, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m NR 12 *—, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m NR 12 C(═O)NH*—, —(CH 2 ) m C(═O)NH(CH 2 ) m NHC(═O)*—, —(CH 2 ) m —, —(CH 2 ) m C(═O)X 2 X 1 C(═O)*—, —(CH 2 ) m (O(CH 2 ) m ) n C(═O)*—, —(CH 2 ) m (O(CH 2 ) m ) n S(═O) 2 (CH 2 ) m *—, —(CH 2 ) m NR 12 (CH 2 ) m C(═O)*—, —X 3 (CH 2 ) m *—, —(CH 2 ) m C(═O)NH*—, —(CH 2 ) m C(═O)NH(CH 2 ) m NHC(═O)(CH 2 ) m *—, —(CH 2 ) m X 3 (CH 2 ) m NHC(═O)(CH 2 ) m *—, —X 3 (CH 2 ) m NHC(═O)(CH 2 ) m *—, —(CH 2 ) m (O(CH 2 ) m ) n *—, —(CH 2 ) m C(═O)NH(CH 2 ) m (O(CH 2 ) m ) n *—, —(CH 2 ) m O(CH 2 ) m NHC(═O)O((C(R 12 ) 2 ) m *—, —X 3 (CH 2 ) m (O(CH 2 ) m ) n NHC(═O)(CH 2 ) m *— and —(CH 2 ) m X 3 (CH 2 ) m (O(CH 2 ) m ) n NHC(═O)(CH 2 ) m *—, wherein in the * of L 1 indicates the point of attachment to R 101 ;

L 2 is

wherein the * of L 2 indicates the point of attachment to L 1 ,

and

L 3 , L 4 , L 5 and L 6 are a bond.

9. An immunoconjugate of Formula (III):

wherein:

Ab represents an antigen binding moiety;

R 1 is —N═CR 4 R5, —N═R 19 , —N═CR 5 R 20 , —NHC(═NR 6 )R 4 , —NHC(═O)R 4 , —NHC(═O)R 20 or —NHR 8 ;

R 2 is —C 1 -C 6 alkyl;

R 4 is —N(R 6 ) 2 or —NR 6 R7;

R 5 is N(R 6 ) 2 ;

each R 6 is independently selected from H and —C 1 -C 6 alkyl;

R 7 is an unsubstituted C3-C 8 cycloalkyl;

or R 7 is a C 3 -C 5 cycloalkyl substituted with 1-3 substituents independently selected from C 1 -C 6 alkyl, oxo, —C(═O)R 18 , —(CH 2 ) m OH, —C(═O)(CH 2 ) m OH, —C(═O)((CH 2 ) m O) n R 12 , —((CH 2 ) m O) n R 12 or a C 1 -C 6 alkyl which is optionally substituted with 1 to 5 hydroxyl;

R 8 is an unsubstituted C-linked 5-6 membered heteroaryl having 1-2 N heteroatoms;

or R 8 is a C-linked 5-6 membered heteroaryl having 1-2 N heteroatoms which is substituted with 1-3 substituents independently selected from C 1 -C 6 alkyl, C 1- C 6 haloalkyl, halogen, —OH, —N(R 6 ) 2 , —CN, —NO 2 , —C(═O)OR 6 and C 1 -C 6 alkoxy;

each R 12 is independently selected from H and C 1 -C 6 alkyl;

R 19 is an unsubstituted C-linked 5-6 membered heterocycloalkyl having 1-2 heteroatoms independently selected from N and 0;

or R 19 is a C-linked 5-6 membered heterocycloalkyl having 1-2 heteroatoms independently selected from N and O which is substituted with 1-3 substituents independently selected from C 1 -C 6 alkyl, C1-C6haloalkyl, halogen and C 1 -C 6 alkoxy;

R 20 is an unsubstituted N-linked 5-6 membered heterocycloalkyl having 1-2 heteroatoms independently selected from N, O and S;

or R 20 is an N-linked 5-6 membered heterocycloalkyl having 1-2 heteroatoms independently selected from N, O and S, which is substituted with 1-2 substituents independently selected from C 1 -C 6 alkyl, C 1 -C 6 haloalkyl, halogen, —C(═O)OR 12 , oxo, —OH and C 1 -C 6 alkoxy;

R 113 is

R 117 is a bold, —NH—, —NHS(═O) 2 ,

R 118 is a bond, tetrazolyl,

L is selected from -L 1 L 2 L 3 L 4 L 5 L 6 -, -L 6 L 5 L 4 L 3 L 2 L 1 -, -L 1 L 2 L 3 L 4 L 5 -, -L 5 L 4 L 3 L 2 L 1 -, -L 1 L 2 L 3 L 4 -, -L 4 L 3 L 2 L 1 -, -L 1 L 2 L 3 -, -L 3 L 2 L 1 -, -L 1 L 2 -, -L 2 L 1 - and -L 1 ,

wherein

L 1 is selected from:

 —(CH 2 ) m —, —C(═O)(CH 2 ) m —, —NR 12 C(═O)(CH 2 ) m —, —C(═O)X 1 X 2 C(═O)(CH 2 ) m —, —C(═O)X 1 X 2 C(═O)(CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —C(═O)X 1 X 2 C(═O)(CH 2 ) m X 3 (CH 2 ) m —, —C(═O)X 1 X 2 C(═O)((CH 2 ) m O) n (CH 2 ) m —, —C(═O)X 1 X 2 C(═O)((CH 2 ) m O)(CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —C(═O)X 1 X 2 C(═O)((CH 2 ) m O)(CH 2 ) m NR 12 C(═O)(CH 2 ) m X 3 (CH 2 ) m —, —C(═O)X 1 X 2 C(═O)((CH 2 ) m O)(CH 2 ) m X 3 (CH 2 ) m —, —C(═O)X 1 X 2 C(═O)(CH 2 ) m NR 12 C(═O)((CH 2 ) m O) n (CH 2 ) m —, —C(═O)X 1 X 2 C(═O)(CH 2 ) m NR 12 C(═O)((CH 2 ) m O)(CH 2 ) m X 3 (CH 2 ) m —, —C(═O)X 1 X 2 (CH 2 ) m X 3 (CH 2 ) m —, —C(═O)X 1 X 2 ((CH 2 ) m O) n (CH 2 ) m —, —C(═O)X 1 X 2 ((CH 2 ) m O) n (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —C(═O)X 1 X 2 ((CH 2 ) m O) n (CH 2 ) m NR 12 C(═O)(CH 2 ) m X 3 (CH 2 ) m —, —C(═O)X 1 X 2 ((CH 2 ) m O)(CH 2 ) m X 3 (CH 2 ) m —, —C(═O)X 1 X 2 (CH 2 ) m NR 12 ((CH 2 ) m O) n (CH 2 ) m —, —C(═O)X 1 X 2 C(═O)(CH 2 ) m NR 12 ((CH 2 ) m O)(CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —C(═O)((CH 2 ) m O) n (CH 2 ) m —, —(CH 2 ) m S(═O) 2 ((CH 2 ) m O) n (CH 2 ) m —, —C(═O)(CH 2 ) m NR 12 (CH 2 ) m —, —C(═O)NR 12 (CH 2 ) m —, —C(═O)NR 12 (CH 2 ) m X 3 (CH 2 ) m —, —C(═O)NR 12 (CH 2 ) m NR 12 C(═O)X 1 X 2 C(═O)(CH 2 ) m —, —C(═O)X 1 C(O)NR 12 (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —C(═O)X 1 C(O)NR 12 (CH 2 ) m X 3 (CH 2 ) m —, C(═O)NR 12 (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —C(═O)NR 12 (CH 2 ) m NR 12 C(═O)(CH 2 ) m X 3 (CH 2 ) m —,

(CH 2 ) m C(═O)NR 12 (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)—, —C(═O)(CH 2 ) m NR 12 (CH 2 ) m C(═O)X 2 X 1 C(═O)—, —(CH 2 ) m X 3 (CH 2 ) m C(═O)X 2 X 1 C(═O)—, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m X 3 —, —X 3 (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m C(O)NR 12 (CH 2 ) m —, —(CH 2 ) m NR 12 C(═O)(CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m O) n (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m (O(CH 2 ) m ) n —, —((C(R 12 ) 2 ) m OC(═O)NR 12 (CH 2 ) m O(CH 2 ) m —, —(CH 2 ) m (O(CH 2 ) m ) n NR 12 C(O)O(C(R 12 ) 2 ) m —, —(CH 2 ) m (O(CH 2 ) m ) n C(O)—, —(CH 2 ) m (O(CH 2 ) m ) n S(O) 2 (CH 2 ) m —, —(CH 2 ) m NR 12 (CH 2 ) m C(═O)—, —(CH 2 ) m O(CH 2 ) m NR 12 C(O)O((C(R 12 ) 2 ) m —, —(CH 2 ) m NR 12 C(═O)—, —(CH 2 ) m C(═O)X 2 X 1 C(═O)NR 12 (CH 2 ) m NR 12 C(═O)—, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m NR 12 C(═O)X 1 -, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m NR 12 C(═O)—,

—((CH 2 ) m O) n (CH 2 ) m —, —(CH2) m (O(CH2) m ) n —, —(CH 2 ) m (O(CH 2 ) m ) n X 3 (CH 2 ) m —, —(CH 2 ) m X 3 ((CH 2 ) m O) n (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m C(═O)—, —C(═O)(CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m O) n (CH 2 ) m X 3 —, —X 3 (CH 2 ) m (O(CH 2 ) m ) n NR 12 C(O)(CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m O) n (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m (O(CH 2 ) m ) n NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m (O(CH 2 ) m ) n C(O)—, —C(═O)((CH 2 ) m O) n (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m C(═O)—, —C(═O)(CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m (O(CH 2 ) m ) n C(═O)—, —C(═O)((CH 2 ) m O) n (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m C(═O)NR 12 (CH 2 ) m —, —(CH 2 ) m NR 12 C(═O)(CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —C(═O)NR 12 (CH 2 ) m NR 12 C(═O)—, —(CH 2 ) m S(CH 2 ) m —, —NR 12 C(═O)(CH 2 ) m —, —NR 12 C(═O)(CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m C(O)NR 12 —, —(CH 2 ) m C(O)NR 12 —, —(CH 2 ) m NR 12 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 —, —X 3 (CH 2 ) m —, —((CH 2 ) m O) n (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m (O(CH 2 ) m ) n —, —NR 12 (CH 2 ) m —, —NR 12 C(R 12 ) 2 (CH 2 ) m —, —(CH 2 ) m C(R 12 ) 2 NR 12 —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m NR 12 —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m NR 12 C(═O)NR 12 —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m NR 12 C(═O)—, —(CH 2 ) m C(═O)X 2 X 1 C(═O)—, —NR 12 (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —NR 12 C(R 12 ) 2 (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m C(R 12 ) 2 NR 12 —, —NR 12 (CH 2 ) m X 3 (CH 2 ) m —, —NR 12 C(R 12 ) 2 (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m C(R 12 ) 2 NR 12 —, —NR 12 C(R 12 ) 2 (CH 2 ) m OC(═O)NR 12 (CH 2 ) m —, —(CH 2 ) m NR 12 C(═O)O(CH 2 ) m C(R 12 ) 2 NR 12 —, —NR 12 C(R 12 ) 2 (CH 2 ) m OC(═O)NR 12 (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m NR 12 C(O)O(CH 2 ) m C(R 12 ) 2 NR 12 —, —NR 12 C(R 12 ) 2 (CH 2 ) m OC(═O)NR 12 ((CH 2 ) m O) n (CH 2 ) m —, —(CH 2 ) m (O(CH 2 ) m ) n NR 12 C(O)O(CH 2 ) m C(R 12 ) 2 NR 12 , —NR 12 C(R 12 ) 2 (CH 2 ) m OC(═O)NR 12 ((CH 2 ) m O) n (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m (O(CH 2 ) m ) n NR 12 C(O)O(CH 2 ) m C(R 12 ) 2 NR 12 —, —(CH 2 ) m X 3 (CH 2 ) m NR 12 —, —NR 12 ((CH 2 ) m O) n (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m (O(CH 2 ) m ) n NR 12 —, —(CH 2 ) m NR 12 —, —NR 12 ((CH 2 ) m O) n (CH 2 ) m —, —NR 12 ((CH 2 ) m O) n (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m (O(CH 2 ) m ) n NR 12 —, —(CH 2 ) m (O(CH 2 ) m ) n NR 12 , —(C(R 12 ) 2 ) m —, —(CH 2 CH 2 O) n —, —(OCH 2 CH 2 ) n —, —(CH 2 ) m O(CH 2 ) m —, —S(═O) 2 (CH 2 ) m —, —(CH 2 ) m S(═O) 2 —, —S(═O) 2 (CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)NR 12 (CH 2 ) m S(═O) 2 —, —S(═O) 2 (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m S(═O) 2 —, —(CH 2 ) m X 2 X 1 C(═O)—, —C(═O)X 1 X 2 (CH 2 ) m —, —(CH 2 ) m (O(CH 2 ) m ) n C(═O)X 2 X 1 C(═O)—, —C(═O)X 1 X 2 C(═O)((CH 2 ) m O) n (CH 2 ) m —, —(CH 2 ) m (O(CH 2 ) m ) n X 2 X 1 C(═O)—, —(CH 2 ) m X 3 (CH 2 ) m X 2 X 1 C(═O)—, —C(═O)X 1 X 2 (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m (O(CH 2 ) m ) n X 2 X 1 C(═O)—, —(CH 2 ) m X 3 (CH 2 ) m C(O)NR 12 (CH 2 ) m NR 12 C(═O), —(CH 2 ) m X 3 (CH 2 ) m C(O)NR 12 (CH 2 ) m C(═O)—, —C(═O)(CH 2 ) m NR 12 C(═O(CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m C(O)NR 12 (CH 2 ) m (O(CH 2 ) m ) n C(═O)—, —C(═O)((CH 2 ) m O) n (CH 2 ) m NR 12 C(═O)(CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m NR 12 C(═O)X 1 X 2 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)X 2 X 1 C(═O)NR 12 (CH 2 ) m —, —X 4 X 1 X 2 C(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)X 2 X 1 X 4 -, —X 1 C(═O)(CH 2 ) m NR 12 C(═O)(CH 2 ) m —, —(CH 2 ) m C(O)NR 12 (CH 2 ) m C(═O)X 1 —, —C(═O)CHR aa NR 12 —, —NR 12 CHR aa C(═O)—, —C(═O)NR 12 —, —C(═O)O—, —S—, —SCH 2 (C═O)NR 12 —, —NR 12 C(═O)CH 2 S—, —S(═O) 2 CH 2 CH 2 S—, —SCH 2 CH 2 S(═O) 2 —, —(CH 2 ) 2 S(═O) 2 CH 2 CH 2 S—, —SCH 2 CH 2 S(═O) 2 CH 2 CH 2 —, —NR 12 C(═S)—, —(CH 2 ) m X 3 (O(CH 2 ) m ) n C(═O)—, —C(═O)((CH 2 ) m O) n X 3 (CH 2 ) m —, —(CH 2 ) m NR 12 C(═O)((CH 2 ) m O) n (CH 2 ) m —, —(CH 2 ) m (O(CH 2 ) m ) n C(═O)NR 12 (CH 2 ) m —, —(CH 2 ) m NR 12 C(═O)NR 12 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m NR 12 C(═O)—, —C(═O)NR 12 (CH 2 ) m X 3 (CH 2 ) m —, —NR 12 S(═O) 2 (CH 2 ) m X 3 (CH 2 ) m —, —(CH 2 ) m X 3 (CH 2 ) m S(O) 2 NR 12 —,

R 24 is H or Me;

each R 25 is independently selected from H or C 1-4 alkyl;

R 26 is

R aa is H or a side chain of an amino acid selected from alanine, tryptophan, tyrosine, phenylalanine, leucine, isoleucine, valine, asparagine, glutamic acid, glutamine, aspatic acid, histidine, arginine, lysine, cysteine, methionine, serine, threonine, citrulline, ornithine, phenylglycine and t-butylglycine;

R 30 is H, —CH 3 or phenyl;

R 32 is independently selected from H, C 1-4 alkyl, phenyl, pyrimidine and pyridine;

R 33 is independently selected from

R 34 is independently selected from H, C 1-4 alkyl, and C 1-6 haloalkyl;

X 1 is self immolative spacer selected from

X 2 is dipeptide selected from

X 3

 and

X 4 is

y is an integer from 1 to 16;

L 2 , L 3 , L 4 , L 5 , and L 6 are each independently selected from a bond and L 1 ;

each m is independently selected from 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10,

and

each n is independently selected from 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 and 18.

10. The immunoconjugate of claim 9 , wherein R 1 is —N═CR 4 R 5 , —N═R 19 or —N═CR 5 R 20 .

11. The immunoconjugate of claim 9 , herein:

R 1 is —N═CR 4 R 5 ;

R 4 is —N(R 6 ) 2 ;

R 5 is N(R 6 ) 2 ;

and

each R 6 is independently selected from —C 1 -C 6 alkyl.

12. The immunoconjugate of claim 9 , wherein R 12 is H, —CH 3 or —CH 2 CH 3 .

13. The immunoconjugate of claim 9 , wherein R 2 is methyl, ethyl, isopropyl or sec-butyl.

14. The immunoconjugate of claim 9 , wherein:

L 1 is selected from —*(CH 2 ) m X 3 (CH 2 ) m —, —*(CH 2 ) m X 3 —, —*C(═O)(CH 2 ) m —, —*NHC(═O)(CH 2 ) m —, —(CH 2 ) m —, —*(CH 2 ) m C(═O)NH(CH 2 ) m NHC(═O)(CH 2 ) m —, —*(CH 2 ) m C(═O)NH(CH 2 ) m X 3 (CH 2 ) m —, —*(CH 2 ) m C(═O)NH(CH 2 ) m X 3 —, —*(CH 2 ) m O) n (CH 2 ) m —, —*(CH 2 ) m O) n (CH 2 ) m NHC(═O)(CH 2 ) m —, —*((C(R 12 ) 2 ) m OC(═O)NH(CH 2 ) m O(CH 2 ) m —, —*(CH 2 ) m C(═O)NH(CH 2 ) m O) n (CH 2 ) m X 3 —, —*(CH 2 ) m C(═O)NH(CH 2 ) m O) n (CH 2 ) m X 3 (CH 2 ) m —, —*(CH 2 ) m NHC(═O)X 1 X 2 C(═O)(CH 2 ) m —, —*X 4 X 1 X 2 C(═O)(CH 2 ) m —, —*X 1 C(═O)(CH 2 ) m NHC(═O)(CH 2 ) m —, —*S(═O) 2 (CH 2 ) m X 3 (CH 2 ) m —,

—*C(═O)((CH 2 ) m O) n (CH 2 ) m )—, —*C(═O)NH(CH 2 ) m )—, —*C(═O)X 1 X 2 C(═O)(CH 2 ) m —, —*C(═O)((CH 2 ) m O)(CH 2 ) m —, —*(CH 2 ) m S(═O) 2 ((CH 2 ) m O)(CH 2 ) m —, —*C(═O)(CH 2 ) m NR 2 (CH 2 ) m —, —*C(═O)(CH 2 ) m NH(CH 2 ) m —, —*(CH 2 ) m (O(CH 2 ) m ) n —, —*C(═O)(CH 2 ) m X 3 (CH 2 ) m —, —*C(═O)NH(CH 2 ) m —, —*C(═O)((CH 2 ) m O)(CH 2 ) m X 3 (CH 2 ) m —, —*(CH 2 ) m NHC(═O)(CH 2 ) m —, —*C(═O)NH(CH 2 ) m NHC(═O)(CH 2 ) m —, —*C(═O)(CH 2 ) m NHC(═O)(CH 2 ) m —, —*C(═O)((CH 2 ) m O) n (CH 2 ) m NHC(═O)(CH 2 ) m —, —(CH 2 ) m C(═O)NH(CH 2 ) m NHC(═O)(CH 2 ) m —, —*NH 2 S(═O) 2 (CH 2 ) m X 3 (CH 2 ) m —, —*(CH 2 ) m NHC(═O)(CH 2 ) m NHC(═O)(CH 2 ) m — and —C(═O)NH(CH 2 ) m NHC(═O)—, wherein the * of L 1 indicates the point of attachment to R 113 ;

L 2 is a bond,

—S—, —SCH 2 (C═O)NH—, —NHC(═O)CH 2 S—,

—S(═O) 2 CH 2 CH 2 S—, —SCH 2 CH 2 S(═O) 2 —, —(CH 2 ) 2 S(═O) 2 CH 2 CH 2 S— or —SCH 2 CH 2 S(═O) 2 CH 2 CH 2 —, wherein the * of L 2 indicates the point of attachment to L 1 ,

and L 3 , L 4 , L 5 and L 6 are a bond.

15. The immunoconjugate of claim 9 , wherein:

L 1 is selected from —*(CH 2 ) m X 3 (CH 2 ) m —, —*(CH 2 ) m X 3 —, —*C(═O)(CH 2 ) m —, —*NHC(═O)(CH 2 ) m —, —(CH 2 ) m —, —*(CH 2 ) m C(═O)NH(CH 2 ) m NHC(═O)(CH 2 ) m —, —*(CH 2 ) m C(═O)NH(CH 2 ) m X 3 (CH 2 ) m —, —*(CH 2 ) m C(═O)NH(CH 2 ) m X 3 —, —*(CH 2 ) m O) n (CH 2 ) m —, —*(CH 2 ) m O) n (CH 2 ) m NHC(═O)(CH 2 ) m —, —*((C(R 12 ) 2 ) m OC(═O)NH(CH 2 ) m O(CH 2 ) m —, —*(CH 2 ) m C(═O)NH(CH 2 ) m O) n (CH 2 ) m X 3 —, —*(CH 2 ) m C(═O)NH(CH 2 ) m O) n (CH 2 ) m X 3 (CH 2 ) m —, —*(CH 2 ) m NHC(═O)X 1 X 2 C(═O)(CH 2 ) m —, —*X 4 X 1 X 2 C(═O)(CH 2 ) m —, —*X 1 C(═O)(CH 2 ) m NHC(═O)(CH 2 ) m —, —*S(═O) 2 (CH 2 ) m X 3 (CH 2 ) m —,

—*NH 2 S(═O) 2 (CH 2 ) m X 3 (CH 2 ) m —, —*C(═O)((CH 2 ) m O) n (CH 2 ) m )— and —*C(═O)NH(CH 2 ) m )—, wherein the * of L 1 indicates the point of attachment to R 113 ;

L 2 is

wherein the * of L 2 indicates the point of attachment to L 1 ,

and L 3 , L 4 , L 5 and L 6 are a bond.

16. A pharmaceutical composition comprising an immunoconjugate of claim 9 , and one or more pharmaceutically acceptable carriers.

17. The immunoconjugate of claim 9 , wherein:

R 1 is —N═CR 4 R 5 ; R 4 is —N(R 6 ) 2 ; R 5 is N(R 6 ) 2 ;

each R 6 is methyl;

R 2 is isopropyl;

R 113 is

R 117 is —NHS(═O) 2 —;

L is -L 1 L 2 -;

L 1 is selected from —*(CH 2 ) m X 3 (CH 2 ) m —, wherein the * indicates the point of attachment to R 113 ;

X 3 is

L 2 is

wherein the * of L 2 indicates the point of attachment to L 1 ,

each m is independently selected from 1, 2 or 3;

and

y is 1, 2, 3 or 4.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2017
From: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC., DBA GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION
To: NOVARTIS AG
Reel/Frame 041532/0626 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2017
From: WAN, YONGQIN; WANG, XING; PAN, SHIFENG; UNO, TETSUO; GRUNEWALD, JAN; GEIERSTANGER, BERNHARD HUBERT; OU, WEIJIA
To: NOVARTIS INSTITUTE FOR FUNCTIONAL GENOMICS, INC., DBA GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION
Reel/Frame 041939/0712 →
Continuity (2)
Provisional Application 62011961 · Jun 13, 2014
Related Publication 20170121282A1 · May 4, 2017